Adjuvant activities of B pentamers of LT-IIa and LT-IIb enterotoxin
    2.
    发明申请
    Adjuvant activities of B pentamers of LT-IIa and LT-IIb enterotoxin 审中-公开
    LT-IIa和LT-IIb肠毒素B五聚体的辅助活性

    公开(公告)号:US20060182765A1

    公开(公告)日:2006-08-17

    申请号:US11354497

    申请日:2006-02-15

    IPC分类号: A61K39/02

    CPC分类号: A61K39/39 A61K2039/55544

    摘要: The present invention provides a method for enhancing an immunological response to an antigen. The method comprises administering to an individual a composition comprising an antigen and an isolated LT-IIa-B pentamer or a mutant thereof, or an isolated LT-IIb-B pentamer or a mutant thereof. The selected LT-II-B pentamer acts as an adjuvant to enhance the immunological response to the co-administered antigen.

    摘要翻译: 本发明提供增强对抗原的免疫应答的方法。 该方法包括向个体施用包含抗原和分离的LT-IIa-B五聚体或其突变体或分离的LT-IIb-B五聚体或其突变体的组合物。 选择的LT-II-B五聚体作为佐剂以增强对共同施用的抗原的免疫应答。

    Mucosal immunogens for novel vaccines
    3.
    发明授权
    Mucosal immunogens for novel vaccines 失效
    新型疫苗的粘膜免疫原

    公开(公告)号:US6030624A

    公开(公告)日:2000-02-29

    申请号:US912180

    申请日:1997-08-15

    摘要: The present invention provides chimeric proteins such as Salivary Binding Protein (SBR) coupled to the B subunit of cholera toxin. Such a chimeric protein, when expressed in attenuated Salmonella typhymurium produces significant increases in serum IgG and salivary IgA antibody levels after oral immunization. In another embodiment of the present invention, the recombinant plasmid contains a salivary binding protein-cholera toxin A2/B chimeric protein expressed in E. coli. Intragastric immunization of SBR coupled to CTB in this chimeric protein form leads to increased antigen responsive T cells. In another embodiment of the present invention, the recombinant plasmid contains a salivary binding protein-cholera toxin.sup..DELTA.A1 chimeric protein expressed in Salmonella typhimurium. Oral immunization using this recombinant plasmid results in increased serum IgG responses to antigen. Oral immunization using this recombinant plasmid also resulted in increased salivary IgA antibody responses to antigen.

    摘要翻译: 本发明提供了与霍乱毒素B亚基偶联的嵌合蛋白如唾液结合蛋白(SBR)。 当在减毒的沙门氏菌中表达时,这种嵌合蛋白在口服免疫后产生血清IgG和唾液IgA抗体水平的显着增加。 在本发明的另一个实施方案中,重组质粒含有在大肠杆菌中表达的唾液结合蛋白 - 霍乱毒素A2 / B嵌合蛋白。 在该嵌合蛋白质形式中与CTB偶联的SBR的内部免疫导致增加的抗原应答性T细胞。 在本发明的另一个实施方案中,重组质粒含有在鼠伤寒沙门氏菌中表达的唾液结合蛋白 - 霍乱毒素DELTA A1嵌合蛋白。 使用这种重组质粒进行口服免疫可导致血清IgG对抗原的反应。 使用这种重组质粒的口服免疫也导致唾液IgA抗体对抗原的反应增加。